Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Gliomatosis cerebri
ADR ID BADD_A09980
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.30      Nervous system neoplasms malignant and unspecified NEC
16.30.02      Glial tumours malignant
16.30.02.008      Gliomatosis cerebri
17      Nervous system disorders
17.20      Nervous system neoplasms malignant and unspecified NEC
17.20.02      Glial tumours malignant
17.20.02.008      Gliomatosis cerebri
Description Neoplasms composed of neuroepithelial cells, which have the capacity to differentiate into NEURONS, oligodendrocytes, and ASTROCYTES. The majority of craniospinal tumors are of neuroepithelial origin. (From Dev Biol 1998 Aug 1;200(1):1-5) [MeSH]
MedDRA Code 10066254
MeSH ID D018302
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Gliomatosis cerebri | Neoplasms, Neuroepithelial | Neuroepithelial Tumors | Neuroepithelial Tumor | Tumor, Neuroepithelial | Tumors, Neuroepithelial | Neuroepithelial Neoplasms | Neoplasm, Neuroepithelial | Neuroepithelial Neoplasm | Spongioblastoma, Polar | Polar Spongioblastoma | Polar Spongioblastomas | Spongioblastomas, Polar | Gliomatosis Cerebri | Astroblastoma | Astroblastomas | Ependymoastrocytoma | Ependymoastrocytomas
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02464Fingolimod0.000241%
The 1th Page    1    Total 1 Pages